TY - JOUR
T1 - Precise and efficient nucleotide substitution near genomic nick via noncanonical homology-directed repair
AU - Nakajima, Kazuhiro
AU - Zhou, Yue
AU - Tomita, Akiko
AU - Hirade, Yoshihiro
AU - Gurumurthy, Channabasavaiah B.
AU - Nakada, Shinichiro
N1 - Funding Information:
We thank F. Zhang and M. Jasin for plasmids. We also thank T. Takahashi, T. Ogi, B. Shiotani, T. Mashimo, M. Ohtsuka, and H. Sasanuma for useful discussions, and K. Nanba for technical support. We also thank CentMeRE, Graduate School of Medicine, Osaka University, for technical assistance. This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (JP26241014 and JP16K12596: S.N.), the Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development (17ek0109229s07 and 16ek0109035h0003: S.N.), a Grant-in-Aid for JSPS Research Fellow (JPA15J047380: K.N.), the Takeda Science Foundation, The Naito Foundation, and The Sumitomo Foundation (S.N.).
Publisher Copyright:
© 2018 Nakajima et al.
PY - 2018/2
Y1 - 2018/2
N2 - CRISPR/Cas9, which generates DNA double-strand breaks (DSBs) at target loci, is a powerful tool for editing genomes when codelivered with a donor DNA template. However, DSBs, which are the most deleterious type of DNA damage, often result in unintended nucleotide insertions/deletions (indels) via mutagenic nonhomologous end joining. We developed a strategy for precise gene editing that does not generate DSBs. We show that a combination of single nicks in the target gene and donor plasmid (SNGD) using Cas9D10A nickase promotes efficient nucleotide substitution by gene editing. Nicking the target gene alone did not facilitate efficient gene editing. However, an additional nick in the donor plasmid backbone markedly improved the gene-editing efficiency. SNGD-mediated gene editing led to a markedly lower indel frequency than that by the DSB-mediated approach. We also show that SNGD promotes gene editing at endogenous loci in human cells. Mechanistically, SNGD-mediated gene editing requires long-sequence homology between the target gene and repair template, but does not require CtIP, RAD51, or RAD52. Thus, it is considered that noncanonical homology-directed repair regulates the SNGD-mediated gene editing. In summary, SNGD promotes precise and efficient gene editing and may be a promising strategy for the development of a novel gene therapy approach.
AB - CRISPR/Cas9, which generates DNA double-strand breaks (DSBs) at target loci, is a powerful tool for editing genomes when codelivered with a donor DNA template. However, DSBs, which are the most deleterious type of DNA damage, often result in unintended nucleotide insertions/deletions (indels) via mutagenic nonhomologous end joining. We developed a strategy for precise gene editing that does not generate DSBs. We show that a combination of single nicks in the target gene and donor plasmid (SNGD) using Cas9D10A nickase promotes efficient nucleotide substitution by gene editing. Nicking the target gene alone did not facilitate efficient gene editing. However, an additional nick in the donor plasmid backbone markedly improved the gene-editing efficiency. SNGD-mediated gene editing led to a markedly lower indel frequency than that by the DSB-mediated approach. We also show that SNGD promotes gene editing at endogenous loci in human cells. Mechanistically, SNGD-mediated gene editing requires long-sequence homology between the target gene and repair template, but does not require CtIP, RAD51, or RAD52. Thus, it is considered that noncanonical homology-directed repair regulates the SNGD-mediated gene editing. In summary, SNGD promotes precise and efficient gene editing and may be a promising strategy for the development of a novel gene therapy approach.
UR - http://www.scopus.com/inward/record.url?scp=85041468104&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041468104&partnerID=8YFLogxK
U2 - 10.1101/gr.226027.117
DO - 10.1101/gr.226027.117
M3 - Article
C2 - 29273627
AN - SCOPUS:85041468104
SN - 1088-9051
VL - 28
SP - 223
EP - 230
JO - Genome Research
JF - Genome Research
IS - 2
ER -